Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioFactura

BioFactura
2004 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series B LATEST DEAL TYPE
$6M LATEST DEAL AMOUNT
12 INVESTORS
Description

Developer of a biomanufacturing platform designed for biodefense vaccines and biological drugs. The company's platform is a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical which include cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize patented multiplexed selection technology, enabling physicians to commercializes products to market with faster, lower cost at superior-quality.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 8435 Progress Drive
  • Suite Z
  • Frederick, MD 21701
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioFactura’s full profile, request a free trial.

BioFactura Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Corporate (Series B) 29-Apr-2019 $6M 00.000 Completed Generating Revenue
8. Grant 01-Jan-2018 00000 00.000 Completed Generating Revenue
7. Angel (individual) 26-Apr-2016 00.000 00.000 Completed Generating Revenue
6. Grant 07-Apr-2016 0000 0000 Completed Generating Revenue
5. Accelerator/Incubator 04-Sep-2015 0000 Completed Generating Revenue
4. Grant 15-Sep-2014 0000 Completed Generating Revenue
3. Grant 26-Jun-2012 00.000 0000 Completed Generating Revenue
2. Accelerator/Incubator 31-Jan-2006 $25K $25K Completed Generating Revenue
1. Grant 01-Jan-2006 $3.07M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

BioFactura Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kymab Venture Capital-Backed Cambridge, United Kingdom 000 00000 0000000000 0 00000
00000000 Corporation Austin, TX 00 0000 00000000 0000
0000000 0000000000 Formerly VC-backed Cambridge, United Kingdom 00 00000 00000000 00000
00000 000000000000 Venture Capital-Backed Boston, MA 00 0000 00000000000 0000
00000 000000000000 Venture Capital-Backed Oxfordshire, United Kingdom 00 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

BioFactura Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
University Of Vermont Health Network Corporation Minority 000 0000 000000 0
Wilson Sonsini Goodrich & Rosati Corporation Minority 000 0000 000000 0
Jeffrey Hausfeld Angel (individual) Minority 000 0000 000000 0
Maryland Department of Commerce Government 000 0000 000000 0
St. Louis Development Lender/Debt Provider Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

BioFactura Executive Team (4)

Name Title Board
Seat
Contact
Info
Darryl Sampey Ph.D Chief Executive Officer, President, Board Member, Chief Scientific Officer and Co-Founder
Alex DeSeabra Co-founder, Board Member & Consultant
Jeffrey Hausfeld MD Chief Medical Officer & Chairman

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

BioFactura Board Members (4)

Name Representing Role Since Contact
Info
Alex DeSeabra BioFactura Co-founder, Board Member & Consultant 000 0000
Darryl Sampey Ph.D BioFactura Chief Executive Officer, President, Board Member, Chief Scientific Officer and Co-Founder 000 0000
Jeffrey Hausfeld MD BioFactura Chief Medical Officer & Chairman 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »